Metabolic dysfunction-associated steatotic liver disease: Where does non-alcoholic fatty liver disease in liver transplant recipients fit in this new definition?

被引：2
|
作者：
Choudhary, Narendra Singh [1 ,2 ]
Dhampalwar, Swapnil [1 ]
Saraf, Neeraj [1 ]
Soin, Arvinder S. [1 ]
机构：
[1] Medanta Medicity, Inst Liver Transplantat & Regenerat Med, Gurugram, India
[2] Medanta Medicity Hosp, Sect 38, Delhi, India
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷 / 02期
关键词：
D O I：
10.1016/j.jhep.2023.09.009
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：e77 / e79
页数：3
相关论文
共 50 条
  • [1] Pipeline of New Drug Treatment for Non-alcoholic Fatty Liver Disease/Metabolic Dysfunction-associated Steatotic Liver Disease
    Hu, Ye
    Sun, Chao
    Chen, Ying
    Liu, Yu-Dong
    Fan, Jian-Gao
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2024, 12 (09) : 802 - 814
  • [2] Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease
    Colaci, Carmen
    Gambardella, Maria Luisa
    Scarlata, Giuseppe Guido Maria
    Boccuto, Luigi
    Colica, Carmela
    Luzza, Francesco
    Scarpellini, Emidio
    Mendez-Sanchez, Nahum
    Abenavoli, Ludovico
    [J]. HEPATOMA RESEARCH, 2024, 10
  • [3] Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease
    Younossi, Zobair M.
    Paik, James M.
    Stepanova, Maria
    Ong, Janus
    Alqahtani, Saleh
    Henry, Linda
    [J]. JOURNAL OF HEPATOLOGY, 2024, 80 (05)
  • [4] Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease
    Loomba, Rohit
    Wong, Vincent Wai-Sun
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 150 - 156
  • [5] Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review
    Fateme Ziamanesh
    Mehdi Mohammadi
    Sholeh Ebrahimpour
    Ozra Tabatabaei-Malazy
    Asieh Mosallanejad
    Bagher Larijani
    [J]. Journal of Diabetes & Metabolic Disorders, 2023, 22 : 1083 - 1094
  • [6] Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review
    Ziamanesh, Fateme
    Mohammadi, Mehdi
    Ebrahimpour, Sholeh
    Tabatabaei-Malazy, Ozra
    Mosallanejad, Asieh
    Larijani, Bagher
    [J]. JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 22 (02) : 1083 - 1094
  • [7] Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
    Jung, Han Na
    Jung, Chang Hee
    [J]. DIABETES & METABOLISM JOURNAL, 2023, 47 (02) : 198 - 200
  • [8] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [9] METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IS ASSOCIATED WITH SUBCLINICAL ATHEROSCLEROSIS MORE THAN NON-ALCOHOLIC FATTY LIVER DISEASE
    Park, Jung Gil
    Jang, Jaeyoung
    Lee, Yu Rim
    Kang, Min Kyu
    Jang, Se Young
    Kweon, Young-Oh
    Tak, Won Young
    Park, Soo Young
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1212 - S1212
  • [10] Comparative associations of non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease with risk of incident chronic kidney disease: a cohort study
    Heo, Ji Hye
    Lee, Mi Yeon
    Kim, Seong Hwan
    Zheng, Ming-Hua
    Byrne, Christopher D.
    Targher, Giovanni
    Sung, Ki-Chul
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2024,
12345